Here’s what you should know:
1. Study researchers examined 2,346 middle-aged individuals (median age of 57 years) over 10 years and 2,475 older individuals (median age of 75 years) over two years. In both instances researchers failed to find a statistically significant effect of long-term PPI exposure on cognitive function.
2. Researchers said they saw no instances of cognitive decline when comparing baseline scores to follow-up scores.
3. Researchers concluded the results were in line with another study that showed there was no link between PPI use and mild cognitive impairment.
4. Researchers did note their 2-year follow-up time could’ve been too short to recognize any long-term cognitive decline.
More articles on gastroenterology:
Maine physician: Halting physician-aimed opioid marketing now is ’20 years’ too late
Somnia Anesthesia shakes up leadership team with new appointments — 3 insights
Survey says medical students learn the most about perioperative medicine by pairing anesthesiology with general surgery rotation
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
